Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Spotify Surges After AI Music Deal with Universal Music Group and Investor Day Guidance Shein Acquires Everlane Ethical Luxury Brand Joins FastFashion Giant Accenture Partners with HUMAIN to Accelerate AI Adoption in Saudi Arabia UK Treasury Proposes Supermarket Price Caps to Address Food System Vulnerability ADP Reports Private Payrolls Increase of 109000 in April Exceeding Forecasts Amphastar Pharmaceuticals AMPH Q1 2026 Earnings EPS Misses Estimates by Wide Margin SPMC Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally MRVL Q1 2026 Earnings Slight EPS Miss Despite Positive Market Response Phoenix Education Partners Inc PXED Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response AGX Q1 2026 Earnings Massive EPS Beat Surprises Market Arena Group Holdings AREN Shares Edge Higher as Support Level Holds Piper Sandler PIPR Edges Lower Amid Consolidation Near Key Support Traeger Inc COOK Pulls Back Slightly Remains Above Key Support After Rally Enterprise Products Partners EPD Slips 278 Key Support and Resistance Levels in Focus Gulf States See No Viable Regional Alternative to US Military Shield Against Iran BristolMyers Squibb Gains on Anthropic AI Partnership as Pipeline Momentum Builds BP Ousted Chairman Albert Manifold Disputes Misconduct Allegations Following Abrupt Exit Indias Foodgrain Production Jumps 5 in 202526 as Rice Wheat Hit Records CDZIP Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline Amid Water Resource Development WFC Q1 2026 Earnings EPS Slightly Tops Estimates Amid Mixed Market Sentiment DigitalBridge Group Inc DBRG Q1 2026 Earnings EPS Misses Estimates Amid Digital Infrastructure Headwinds SNAP Q1 2026 Earnings EPS Beat Driven by Cost Discipline Amidst Mixed Revenue Trends Shinhan Financial Group Q4 2025 Earnings Heavy EPS Miss Despite Modest Share Gain TCRT Q4 2023 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue